Hologic Inc (HOLX): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Hologic ( HOLX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.2%. By the end of trading, Hologic rose $0.78 (3.5%) to $22.95 on heavy volume. Throughout the day, 8,086,051 shares of Hologic exchanged hands as compared to its average daily volume of 3,450,800 shares. The stock ranged in a price between $22.18-$23.04 after having opened the day at $22.27 as compared to the previous trading day's close of $22.17. Other companies within the Health Care sector that increased today were: IntelliPharmaCeutics International ( IPCI), up 56.0%, Uroplasty ( UPI), up 36.0%, Biocryst Pharmaceuticals ( BCRX), up 21.5% and Bacterin International Holdings ( BONE), up 16.9%.

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. Hologic has a market cap of $5.8 billion and is part of the health services industry. Shares are up 8.3% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and deteriorating net income.

On the negative front, Mast Therapeutics ( MSTX), down 33.4%, Ampio Pharmaceuticals ( AMPE), down 13.5%, Aoxing Pharmaceutical Company ( AXN), down 12.0% and Hansen Medical ( HNSN), down 10.6% , were all laggards within the health care sector with Biogen Idec ( BIIB) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Hologic Looks Good on the Charts

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers

Cramer: These Sectors Look Bullish (Part III)